Pyrrolo [2, 3-d] pyrimidine derivative targeting EGFR mutation as well as preparation method and application of pyrrolo [2, 3-d] pyrimidine derivative
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- WEST CHINA HOSPITAL SICHUAN UNIV
- Publication Date
- 2020-10-30
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of chemical medicine, and specifically relates to a pyrrolo[2,3-d]pyrimidine derivative targeting EGFR mutation, a preparation method and application thereof. Background technique
[0002] Lung cancer is the malignant tumor with the highest morbidity and mortality worldwide, and the number of deaths due to lung cancer reaches 1.6 million each year. It is the main cause of cancer-related deaths in men (22% of cancer deaths) and women (13.8% of cancer deaths) reason. In the United States, about 14 percent of new cancers are lung cancers. The American Cancer Society estimates there were approximately 234,000 lung cancer cases and 154,000 deaths in the United States in 2018. The situation in my country is equally serious. According to the latest cancer data in China released by the National Cancer Center in January 2019, lung cancer is the malignant tumor with the highest morbidity and mortality in my country. Come unde...